Related Experiment Video

Updated: Jul 25, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

306

Retracted: An Immune-Related Prognostic Risk Model in Colon Cancer by Bioinformatics Analysis

Evidence-Based Complementary And Alternative Medicine

    Evidence-Based Complementary and Alternative Medicine : Ecam
    |June 30, 2023
    PubMed

    Abstract:

    [This retracts the article DOI: 10.1155/2022/3640589.].

    More Related Videos

    Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
    08:12

    Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

    Published on: March 14, 2019

    5.5K
    Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
    06:24

    Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

    Published on: October 13, 2023

    972

    Related Experiment Videos

    Last Updated: Jul 25, 2025

    Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
    06:46

    Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

    Published on: September 27, 2024

    306
    Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
    08:12

    Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

    Published on: March 14, 2019

    5.5K
    Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
    06:24

    Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

    Published on: October 13, 2023

    972

    Related Concept Videos

    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    397
    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
    397

    Articles linked to this work by shared authors, journal, and citation graph.

    Retracted: Pravastatin Reduces Matrix Metalloproteinases Expression and Promotes Cholesterol Efflux in Osteoarthritis Chondrocytes.

    Evidence-based complementary and alternative medicine : eCAM·2023

    Retracted: Influence of Adenoid Hypertrophy on Malocclusion and Maxillofacial Development in Children.

    Evidence-based complementary and alternative medicine : eCAM·2023

    Retracted: Clinical Efficacy of Huangkui Capsule plus Methylprednisolone in the Treatment of Nephropathy and the Effect on Urinary Protein and Serum Inflammatory Factors in Patients.

    Evidence-based complementary and alternative medicine : eCAM·2023

    Retracted: Protective Effects and Molecular Mechanism of Total Flavonoids from Lycium Barbarum Leaves on Photoaged Human Dermal Fibroblasts.

    Evidence-based complementary and alternative medicine : eCAM·2023

    Retracted: Naringin Promotes Osteogenic/Odontogenic Differentiation of Dental Pulp Stem Cells via Wnt/β-Catenin.

    Evidence-based complementary and alternative medicine : eCAM·2023

    Retracted: Clinical Application of Augmented Reality in Computerized Skull Base Surgery.

    Evidence-based complementary and alternative medicine : eCAM·2023

    Correction to "Comparing Verum and Sham Acupuncture in Fibromyalgia Syndrome: A Systematic Review and Meta-Analysis".

    Evidence-based complementary and alternative medicine : eCAM·2026

    Correction to "Antidepressant-Like Effects of Shuyusan in Rats Exposed to Chronic Stress: Effects on Hypothalamic-Pituitary-Adrenal Function".

    Evidence-based complementary and alternative medicine : eCAM·2026

    RETRACTION: Assessment of Toxicity and Beneficiary Effects of Garcinia pedunculata on the Hematological, Biochemical, and Histological Homeostasis in Rats.

    Evidence-based complementary and alternative medicine : eCAM·2026

    RETRACTION: Ganoderma lucidum and Auricularia polytricha Mushrooms Protect against Carbofuran-Induced Toxicity in Rats.

    Evidence-based complementary and alternative medicine : eCAM·2026

    RETRACTION: Antioxidant Properties and Cardioprotective Mechanism of Malaysian Propolis in Rats.

    Evidence-based complementary and alternative medicine : eCAM·2026

    RETRACTION: Antihyperglycemic, Antidiabetic, and Antioxidant Effects of Garcinia pedunculata in Rats.

    Evidence-based complementary and alternative medicine : eCAM·2026

    Postoperative radiotherapy or chemoradiotherapy versus surgery only in non-metastatic head and neck adenoid cystic carcinoma: a retrospective analysis.

    Translational cancer research·2026

    Efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone in stage IIIB-IV squamous non-small cell lung cancer: a systematic review and meta-analysis of phase 3 randomized controlled trials.

    Translational cancer research·2026

    Erratum: Nomogram for predicting cancer-specific mortality risk in endometrial cancer after postoperative radiotherapy.

    Translational cancer research·2026

    Neoadjuvant anthracycline-containing vs. anthracycline-free chemotherapy with dual HER2 blockade in HER2-Positive breast cancer: a Systematic Review and meta-analysis.

    Open medicine (Warsaw, Poland)·2026

    The expert consensus document on minimally invasive upper lobectomy for lung cancer in China.

    Journal of thoracic disease·2026

    Belzutifan-Associated Reversible Heart Failure With Preserved Ejection Fraction in Metastatic Renal Cell Carcinoma.

    IJU case reports·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us